Chlorisondamine
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
trimethyl-[2-(4,5,6,7-tetrachloro-2-methyl-isoindolin-2-ium-2-yl)ethyl]ammonium dichloride
|
|
Identifiers | |
CAS Number | 7701-62-4 ![]() |
ATC code | none |
PubChem | CID: 6244 |
ChemSpider | 6008 ![]() |
UNII | JD3M24F66I ![]() |
ChEMBL | CHEMBL2104531 |
Chemical data | |
Formula | C14H20Cl6N2 |
Molecular mass | 429.04 g/mol |
|
|
|
|
(verify) |
Chlorisondamine is a nicotinic acetylcholine receptor antagonist that produces both neuronal and ganglionic blockade.
Chlorisondamine has been shown to form noncovalent complexes with various biomolecules including sphingomyelin and other associated glycolipids.[1][2][3]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Woods, A. S.; Moyer, S. C.; Wang, H. Y. J.; Wise, R. A., "Interaction of chlorisondamine with the neuronal nicotinic acetylcholine receptor". Journal of Proteome Research 2003, 2 (2), 207–212.
- ↑ Jackson, S. N.; Wang, H. Y. J.; Woods, A. S., "Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS". Journal of the American Society for Mass Spectrometry 2005, 16 (2), 133–138.
- ↑ Woods, A. S.; Ugarov, M.; Egan, T.; Koomen, J.; Gillig, K. J.; Fuhrer, K.; Gonin, M.; Schultz, J. A., "Lipid/peptide/nucleotide separation with MALDI-ion mobility-TOF MS". Analytical Chemistry 2004, 76 (8), 2187–2195.
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Quaternary ammonium compounds
- Chloroarenes
- Nervous system drug stubs